OR WAIT 15 SECS
Aprecia, which has an FDA-approved 3D-printed medication, will collaborate with Purdue’s College of Pharmacy to accelerate development in 3DP pharmaceuticals.
Aprecia Pharmaceuticals, a pharmaceutical company headquartered in Blue Ash, OH, and Purdue University's College of Pharmacy announced on Feb. 20, 2020 that they are partnering on future 3DP pharmaceutical equipment and medications. Aprecia was the first company to receive FDA approval, in 2015, for a 3D-printed medication.
"Aprecia’s mission is to maximize and expand its 3DP technology platform through global partnerships that will provide pharmaceutical solutions for unmet patient needs," said Chris Gilmore, Aprecia CEO, in the press release. "Purdue University is an esteemed institution, and we are confident that this partnership will advance our future in 3DP pharmaceutical research and development."
"Purdue University is committed to its investment in drug discovery and development as well as student and faculty enrichment that will continue to yield global advancement in medicine and healthcare," added Eric Barker, dean of Purdue's College of Pharmacy, in the press release. "As a College, our mission is to prepare the next generation of leaders in pharmacy. Partnering with Aprecia aligns perfectly with that mission. We are excited to combine our talented students and faculty with the successful researchers at Aprecia to work together to accelerate discoveries in this emerging field."